Effect of astragalus membranacaus injection on activity of intestinal mucosal mast cells and inflammatory response after hemorrahagic shock-reperfusion in rats

Zhongguo Zhongyao Zazhi

Volumn 32, Issue 14, 2007, Pages 1436-1440

  Luo, Gang Jian ^a   Gan, Xiao Liang ^a   Hei, Zi Qing ^a   Chen, Li Xin ^a   Li, Shang Rong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hemorrhage shock; Histamine; Intestinal mucosal mast cells; Reperfusion; Tumor necrosis factor

Indexed keywords

HERBACEOUS AGENT; MALONALDEHYDE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; ASTRAGALUS MEMBRANACEUS; CHEMISTRY; DRUG EFFECT; FEMALE; HEMORRHAGIC SHOCK; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALE; MAST CELL; METABOLISM; PATHOLOGY; RANDOMIZATION; RAT; REPERFUSION INJURY; SMALL INTESTINE; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ASTRAGALUS MEMBRANACEUS; DRUGS, CHINESE HERBAL; FEMALE; INJECTIONS, INTRAVENOUS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MALONDIALDEHYDE; MAST CELLS; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPERFUSION INJURY; SHOCK, HEMORRHAGIC; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547735075     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arumugan T, Shiels I, Margolins B, et al. Pirfenidore attenuates ischemia-reperfusion injury in rat small intestine [J]. Cli Exp Pharmacol Physiol, 2002, 29(11): :996.
2. Deitch E. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings [J]. Surgery, 2002, 131: 241.
3. Chinese source
4. Chinese source
5. Chinese source
6. Chaudry I H. Rat and mouse models of hypovolemic-traumatic shock[M]. In:Schlag G, Redl H, ed. Pathophysiology of shock, sepsis and organ failure. Berlin: Springer-Verlag, 1993: 371.
7. Chiu C J, Mcardle A H, Brown R, et al. Intestinal mucosal lesion in low flow states[J]. Arch Surg, 1970, 101:478.
8. Alicia B P, Maria I R, Ramon S P. Role of mast cells in gastrointestinal mucosal defense[J]. Biocell, 2003, 27(2): 163.
9. Rangacgari P K. Histamine: mercurial messenger in the gut[J]. Am J Physiol, 1997, 260: G1.
10. Boros M, Kaszaki J, Ordogh B, et al. Mast cell degranulation prior to ischemia decreases ischemia-reperfusion injury in the canine small intestine[J]. Inflamm Res, 1999, 48(4): :193.
11. Chinese source
12. Kollias G, Douni E, Kassious G, et al. On the role of tumor necrosis factor and receptors in models of multiple organ failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease[J]. Immunol Rev, 1999, 169: 175.
13. Liu Bao-lin, Yoshihiro Inami, Hiroyuki Tanaka, et al. Vaticanol (B, C and G), α-Viniferin, and hopeaphenol inhibit mediator release from bone marrow derived mouse mast cells in vitro[J]. Chin J Nat Med, 2004, 2(3): 176.
14. Kelley J, Hemontolor G, Younis W, et al. Mast cell activation by lipoproteins[J]. Methods Mol Biol, 2006, 315: 341.
15. Yu L C, Perdue M. Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress [J]. Immend Rev, 2001, 179: 61.